Adult stem cells and regenerative medicine—a symposium report

Author:

Cable Jennifer1,Fuchs Elaine2,Weissman Irving3,Jasper Heinrich4,Glass David5,Rando Thomas A.6,Blau Helen7,Debnath Shawon8,Oliva Anthony9,Park Sangbum10,Passegué Emmanuelle11,Kim Carla12131415,Krasnow Mark A.16

Affiliation:

1. Science Writer New York New York

2. Robin Chemers Neustein Laboratory of Mammalian Cell Biology and Development, Howard Hughes Medical Institute The Rockefeller University New York New York

3. Pathology Stem Cell Institute Stanford University Stanford California

4. Genentech San Francisco California

5. Novartis Cambridge Massachusetts

6. Neurology & Neurological Sciences Stanford University Stanford California

7. Microbiology and Immunology ‐ Baxter Labs Stanford University Stanford California

8. Department of Pathology and Laboratory Medicine Weill Cornell Medical College New York New York

9. Longeveron Miami Florida

10. Department of Genetics Yale University New Haven Connecticut

11. Columbia Stem Cell Initiative, Department of Genetics & Development Columbia University New York New York

12. Dana Farber/Harvard Cancer Center Boston Massachusetts

13. Division of Hematology/Oncology, Stem Cell Program, Department of Pediatrics Boston Children's Hospital Boston Massachusetts

14. Genetics Department Harvard Medical School Boston Massachusetts

15. Harvard Stem Cell Institute Cambridge Massachusetts

16. Department of Biochemistry Stanford University Stanford California

Funder

National Heart, Lung, and Blood Institute

National Science Foundation

March of Dimes Foundation

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Reference52 articles.

1. National Cancer Institute.2005.Blood‐forming stem cell transplants. September 9 2005. Accessed April 17 2019.https://www.cancer.gov/about-cancer/treatment/types/stem-cell-transplant/stem-cell-fact-sheet.

2. U.S. Food and Drug Administration.2019.Approved cellular and gene therapy products. May 24 2019. Accessed August 28 2019.http://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/approved-cellular-and-gene-therapy-products.

3. European Medicines Agency.2018.Holoclar. September 17 2018. Accessed April 17 2019.https://www.ema.europa.eu/en/medicines/human/EPAR/holoclar.

4. Rapid functional dissection of genetic networks via tissue-specific transduction and RNAi in mouse embryos

5. Pioneer factors govern super-enhancer dynamics in stem cell plasticity and lineage choice

Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3